BioNexus Gene Lab Corp Common stock
BGLC
$1.29+3.26%
End of day · as of Oct 11, 2026, 8:02 PM ET
Mkt cap
$6.09M
EV/Sales
0.49
P/E ratio
N/A
FY2025 Revenue
$7.42M
EPS (H1 2026)
$-0.34
Gross Margin (FY2025)
14.62%
Profit Margin (FY2025)
-40.20%
Beta
N/A
Div yield
N/A
Sector
Materials
BioNexus Gene Lab Corp Common stock (BGLC) is a specialty chemicals company listed on NASDAQ.
Latest reported BGLC revenue for 2025-12-31 was $7.4M. Net income was -$3.0M. Revenue was down 21.9% from 2024-12-31 to 2025-12-31. BGLC currently screens at market cap $6.1M.
Use this BGLC research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full BGLC income, balance, and cash tables.
BioNexus Gene Lab Corp Common stock (BGLC) is a specialty chemicals company in the Basic Materials sector.
Latest cached BioNexus Gene Lab Corp Common stock (BGLC) revenue for Dec 31, 2025 was $7.4M. Net income was -$3.0M. Statements: https://lician.com/financials/bglc
BioNexus Gene Lab Corp Common stock (BGLC) market capitalization is $6.1M on the latest cached snapshot.
BioNexus Gene Lab Corp Common stock (BGLC) cached previous close $1.25; day range $1.21 – $1.29; volume 3,875. Session quote: https://lician.com/quote/bglc
BioNexus Gene Lab Corp Common stock (BGLC) latest cached earnings event is "BGLC earnings" on Aug 17, 2026. Earnings calendar: https://lician.com/earnings
The latest cached BGLC filing is 8-K · Oct 7, 2026. Filings: https://lician.com/sec/bglc